153 related articles for article (PubMed ID: 23290275)
1. The clinical impact of the American College of Surgeons Oncology Group Z-0011 trial--results from the BreastSurgANZ National Breast Cancer Audit.
Ainsworth RK; Kollias J; Le Blanc A; De Silva P
Breast; 2013 Oct; 22(5):733-5. PubMed ID: 23290275
[TBL] [Abstract][Full Text] [Related]
2. Subsequent axillary surgery after sentinel lymph node biopsy: results from the BreastSurgANZ Quality Audit 2006-2010.
Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
Breast; 2013 Dec; 22(6):1215-9. PubMed ID: 24157405
[TBL] [Abstract][Full Text] [Related]
3. Surgical management of early stage invasive breast cancer: a practice guideline.
McCready D; Holloway C; Shelley W; Down N; Robinson P; Sinclair S; Mirsky D; ;
Can J Surg; 2005 Jun; 48(3):185-94. PubMed ID: 16013621
[TBL] [Abstract][Full Text] [Related]
4. Have the American College of Surgeons Oncology Group Z0011 trial results influenced the number of lymph nodes removed during sentinel lymph node dissection?
Robinson KA; Pockaj BA; Wasif N; Kaufman K; Gray RJ
Am J Surg; 2014 Dec; 208(6):1060-4; discussion 1063-4. PubMed ID: 25312842
[TBL] [Abstract][Full Text] [Related]
5. Update on the NSABP and ACOSOG breast cancer sentinel node trials.
White RL; Wilke LG
Am Surg; 2004 May; 70(5):420-4. PubMed ID: 15156950
[TBL] [Abstract][Full Text] [Related]
6. Impact of the American College of Surgeons Oncology Group Z0011 Randomized Trial on the Number of Axillary Nodes Removed for Patients with Early-Stage Breast Cancer.
Yao K; Liederbach E; Pesce C; Wang CH; Winchester DJ
J Am Coll Surg; 2015 Jul; 221(1):71-81. PubMed ID: 25899731
[TBL] [Abstract][Full Text] [Related]
7. Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
Hennigs A; Köpke M; Feißt M; Riedel F; Rezai M; Nitz U; Moderow M; Golatta M; Sohn C; Schneeweiss A; Heil J
Breast Cancer Res Treat; 2019 Jan; 173(2):429-438. PubMed ID: 30315437
[TBL] [Abstract][Full Text] [Related]
8. Relevance of the American College of Surgeons Oncology Group Z0011 Trial to breast cancer in the Australian setting.
Ngui NK; Elder EE; Jayasinghe UW; French J
ANZ J Surg; 2013 Dec; 83(12):924-8. PubMed ID: 24289051
[TBL] [Abstract][Full Text] [Related]
9. The evolving role of axillary lymph node dissection in the modern era of breast cancer management.
Barry JM; Weber WP; Sacchini V
Surg Oncol; 2012 Jun; 21(2):143-5. PubMed ID: 21440434
[TBL] [Abstract][Full Text] [Related]
10. Applicability of the ACOSOG Z0011 criteria in women with high-risk node-positive breast cancer undergoing breast conserving surgery.
Chung A; Gangi A; Mirocha J; Giuliano A
Ann Surg Oncol; 2015 Apr; 22(4):1128-32. PubMed ID: 25300606
[TBL] [Abstract][Full Text] [Related]
11. Initial axillary surgery: results from the BreastSurgANZ Quality Audit.
Chong C; Walters D; de Silva P; Taylor C; Spillane A; Kollias J; Pyke C; Campbell I; Maddern G
ANZ J Surg; 2015 Oct; 85(10):777-82. PubMed ID: 24251959
[TBL] [Abstract][Full Text] [Related]
12. The exportability of the ACOSOG Z0011 criteria for omitting axillary lymph node dissection after positive sentinel lymph node biopsy findings: a multicenter study.
Delpech Y; Bricou A; Lousquy R; Hudry D; Jankowski C; Willecocq C; Thoury A; Loustalot C; Coutant C; Barranger E
Ann Surg Oncol; 2013 Aug; 20(8):2556-61. PubMed ID: 23456432
[TBL] [Abstract][Full Text] [Related]
13. A Population-Based Study of the Effects of a Regional Guideline for Completion Axillary Lymph Node Dissection on Axillary Surgery in Patients with Breast Cancer.
Tsao MW; Cornacchi SD; Hodgson N; Simunovic M; Thabane L; Cheng J; O'Brien MA; Strang B; Mukherjee SD; Lovrics PJ
Ann Surg Oncol; 2016 Oct; 23(10):3354-64. PubMed ID: 27342830
[TBL] [Abstract][Full Text] [Related]
14. [Management of the axilla in breast cancer: evidences and unresolved issues].
Fodor J; Polgár C; Péley G; Németh G
Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
[TBL] [Abstract][Full Text] [Related]
15. Effect of the American College of Surgeons Oncology Group Z0011 trial on axillary management in breast cancer patients in the Australian setting.
Ngui NK; Hitos K; Hughes TMD
Breast J; 2019 Sep; 25(5):853-858. PubMed ID: 31134730
[TBL] [Abstract][Full Text] [Related]
16. Measuring the impact of the American College of Surgeons Oncology Group Z0011 trial on breast cancer surgery in a community health system.
Wright GP; Mater ME; Sobel HL; Knoll GM; Oostendorp LD; Melnik MK; Chung MH
Am J Surg; 2015 Feb; 209(2):240-5. PubMed ID: 25236187
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
18. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
19. ACOSOG Z-0011 criteria impact on axillary surgery for early breast cancer in clinical practice: Evaluation in a retrospective cohort of 1900 patients.
Dolivet E; Loaec C; Johnson A; Renaudeau C; Boiffard F; Dravet F; Brillaud Meflah V; Classe JM
Eur J Obstet Gynecol Reprod Biol; 2021 Jun; 261():41-45. PubMed ID: 33878635
[TBL] [Abstract][Full Text] [Related]
20. Which sentinel lymph-node (SLN) positive breast cancer patient needs an axillary lymph-node dissection (ALND)--ACOSOG Z0011 results and beyond.
Gatzemeier W; Mann GB
Breast; 2013 Jun; 22(3):211-6. PubMed ID: 23478200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
